Sat, Aug 23, 2014, 9:14 AM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Seattle Genetics Inc. Message Board

  • llabtechtwo llabtechtwo May 23, 2012 6:39 PM Flag

    I posted on cldx's board...

    but 32% ORR in highly expressed GPNMB!!!! Unbelievable this targeted cytotoxin did exactly what is was supposed too!! Just further validation of SGEN's technology!!! TOO COOL!!

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • OK, let's see..............

      In heavily pre-treated triple negative patients who also expressed high levels of the target GPNMB the response rate was 36% versus 0% ( nilche / nada / nothing ) for the comparator drug treatments.

      OK, my eyebrows are raised.

      Good luck to all!

      Ricardo
      ------------

      Disclosure: Ricardo has a huge long term position in SGEN and a more modest holding of CLDX. The man is nuts, so you may want to consider you investment options on your own.

      • 1 Reply to Ricardouno
      • My eyebrows are raised because the sp tanked AH instead of shooting to the moon. May just be non serious investors taking profits. Hope it goes back to $5 again.

        Ricardo, are you familiar with study design? I'm a bit worried the GPNMB expression cutoff of 25%. If <25% of tumors have GPNMB, did they lump that into the 5%? IF they lumped all those with expression >15 or 20% could they have had a higher number of patients that actually responded? Just wondering if the 25% was set after data analysis and not prior.

 
SGEN
42.86+0.36(+0.85%)Aug 22 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.